1. Home
  2. EVGO vs RZLT Comparison

EVGO vs RZLT Comparison

Compare EVGO & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVgo Inc.

EVGO

EVgo Inc.

HOLD

Current Price

$2.79

Market Cap

396.1M

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.37

Market Cap

326.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVGO
RZLT
Founded
2010
2010
Country
US
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
396.1M
326.4M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
EVGO
RZLT
Price
$2.79
$3.37
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$5.82
$9.17
AVG Volume (30 Days)
3.5M
2.8M
Earning Date
01-01-0001
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.32
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$45.28
N/A
Revenue Next Year
$29.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$1.07
52 Week High
$5.18
$11.46

Technical Indicators

Market Signals
Indicator
EVGO
RZLT
Relative Strength Index (RSI) 40.49 49.49
Support Level $2.67 $3.42
Resistance Level $3.32 $4.09
Average True Range (ATR) 0.18 0.30
MACD -0.03 0.09
Stochastic Oscillator 16.15 43.41

Price Performance

Historical Comparison
EVGO
RZLT

About EVGO EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: